Raju Mohan - Dec 2, 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Dec 2, 2022
Transactions value $
-$8,691,087
Form type
4
Date filed
12/6/2022, 04:00 PM
Previous filing
Feb 4, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$8.04M -277K -15.04% $29.01 1.56M Dec 2, 2022 Direct F1
transaction VTYX Common Stock Sale -$564K -19.9K -1.27% $28.33 1.54M Dec 5, 2022 Direct F2
transaction VTYX Common Stock Sale -$90.6K -3.11K -0.2% $29.15 1.54M Dec 5, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 276,997 shares sold in the price range of $28.865 to $29.21. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 19,896 shares sold in the price range of $28.08 to $29.0623. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 3,107 shares sold in the price range of $29.12 to $29.89. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.